Prostaglandin E2 (PGE2) is the major renal cyclooxygenase metabolite of arachidonic acid and a potent modulator of a wide variety of cellular responses including vascular tone as well as water and ion transport. Recently it has become apparent that most of PGE2's effects are mediated via specific guanine nucleotide regulatory protein coupled receptors. In the cortical collecting duct (CCD), PGE2 modulates water reabsorption by either increasing or decreasing levels of cAMP and inhibits sodium transport via its recently described ability to elevate intracellular calcium levels in this segment of the nephron. The molecular basis for these multiple effects of PGE2 remain unclear, but may be accounted for by multiple PGE2 receptors. Based on the activity of PGE2 analogs and their ability to act as either relaxors or constrictors of smooth muscle, four different subtypes of PGE2 receptor have been proposed, designated EP1, EP2, EP3, and EP4. We propose that multiple receptor subtypes are present on renal epithelial cells as well and may specifically account for the various effects of PGE2 in the CCD. We have isolated four putative EP receptor subtypes from a rabbit renal cortex cDNA library using a homology based cloning strategy. We will characterize these renal EP receptor clones defining the ligand binding and signal transduction properties of each subtype using mammalian cell lines transfected with each receptor subtype. In vivo studies will address questions of receptor regulation by drugs which alter PGE2 synthesis, and will also examine the distribution of the receptor subtypes at the animal, organ and cellular levels. We will isolate the gene(s) encoding these cDNAs to determine their molecular organization, which will provide insight into the mechanism of receptor regulation. The completion of the project should allow the isolation of a PGE2 receptor gene, expression of the receptor in heterologous systems, and detailed characterization of its hormone binding and signaling properties, and this in turn will address the functional significance of the cloned EP receptor subtypes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK046205-02
Application #
2145390
Study Section
General Medicine B Study Section (GMB)
Project Start
1993-08-01
Project End
1997-07-31
Budget Start
1994-08-01
Budget End
1995-07-31
Support Year
2
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pediatrics
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Ceddia, Ryan P; Lee, DaeKee; Maulis, Matthew F et al. (2016) The PGE2 EP3 Receptor Regulates Diet-Induced Adiposity in Male Mice. Endocrinology 157:220-32
Natarajan, Chandramohan; Hata, Aaron N; Hamm, Heidi E et al. (2013) Extracellular loop II modulates GTP sensitivity of the prostaglandin EP3 receptor. Mol Pharmacol 83:206-16
Downey, Jason D; Saleh, Sam A; Bridges, Thomas M et al. (2013) Development of an in vivo active, dual EP1 and EP3 selective antagonist based on a novel acyl sulfonamide bioisostere. Bioorg Med Chem Lett 23:37-41
Zhang, Jian; Zou, Fangfang; Tang, Juan et al. (2013) Cyclooxygenase-2-derived prostaglandin Eýýý promotes injury-induced vascular neointimal hyperplasia through the E-prostanoid 3 receptor. Circ Res 113:104-14
Singh, Pratibha; Hoggatt, Jonathan; Hu, Peirong et al. (2012) Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells. Blood 119:1671-82
Chen, Lihong; Miao, Yifei; Zhang, Yahua et al. (2012) Inactivation of the E-prostanoid 3 receptor attenuates the angiotensin II pressor response via decreasing arterial contractility. Arterioscler Thromb Vasc Biol 32:3024-32
Shi, Ju; Wang, Qian; Johansson, Jenny U et al. (2012) Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease. Ann Neurol 72:788-98
Bartlett, Christina S; Boyd, Kelli L; Harris, Raymond C et al. (2012) EP1 disruption attenuates end-organ damage in a mouse model of hypertension. Hypertension 60:1184-91
Jewell, Mark L; Breyer, Richard M; Currie, Kevin P M (2011) Regulation of calcium channels and exocytosis in mouse adrenal chromaffin cells by prostaglandin EP3 receptors. Mol Pharmacol 79:987-96
Downey, Jason D; Sanders, Charles R; Breyer, Richard M (2011) Evidence for the presence of a critical disulfide bond in the mouse EP3? receptor. Prostaglandins Other Lipid Mediat 94:53-8

Showing the most recent 10 out of 52 publications